Biotech entity
pharma is the sole category represented across all 1 tracked stories. Rare Cancers Law is most often covered alongside National Health Service (NHS), which appears in 1 of these 1 story. The tracked stories average 4 original sources each. Rare Cancers Law appears in 1 tracked Biotech story from February 27, 2026.
Last mentioned: Feb 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Rare Cancers Law is most often covered alongside National Health Service (NHS), which appears in 1 of these 1 story. The tracked stories average 4 original sources each. Rare Cancers Law appears in 1 tracked Biotech story from February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Rare Cancers Law. Shared-story counts are live from our verified record — not editorial picks.
Target Implementation
Anticipated date for the law to take effect, enabling new regulatory and funding mechanisms.
Parliamentary Debate
The bill is expected to move through the House of Commons for debate and potential amendments.
Stakeholder Consultation
A formal period for biotech firms, patient advocacy groups, and the NHS to provide feedback on the draft.
Draft Law Unveiled
The UK Government releases the initial draft of the Rare Cancers Law focusing on brain tumors.
The UK government has unveiled a draft Rare Cancers Law designed to streamline the development and delivery of treatments for incurable brain tumors. This legislative framework aims to bridge the funding gap and accelerate clinical trial access for high-mortality, low-prevalence oncological conditions.
Rare Cancers Law is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
